NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared with SoC Antiemetic Prophylaxis By Ogkologos - November 18, 2025 6 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from MyRisk study Source RELATED ARTICLESMORE FROM AUTHOR A Short-Course Dose Escalation Strategy Could Improve Ability to Reach Target Dose of Adjuvant Abemaciclib in High-Risk Early-Stage HR-positive, HER2-negative Breast Cancer FDA Approves Ziftomenib for Relapsed or Refractory Acute Myeloid Leukaemia with a NPM1 Mutation ESMO Publishes First-Ever Guidance on Validation Requirements for AI-Based Biomarkers in Oncology MOST POPULAR 3-in-1 Approach Helps Women in Rural Areas Get Cancer Screenings June 1, 2023 Long-Term Clinical Benefit with Nivolumab Plus Ipilimumab Extends Beyond Treatment Discontinuation... October 18, 2022 FDA Approves Amivantamab-vmjw with Carboplatin and Pemetrexed for NSCLC with EGFR... September 24, 2024 Celebrating 20 Years of Cancer.Net: How We’ve Worked to Empower People... May 3, 2022 Load more HOT NEWS “Glossy” Awareness Campaigns Weren’t Representing Her Cancer, So She Started #TrueCancerBodies Encouraging Antitumour Activity of First-Line Atezolizumab Plus Paclitaxel and Bevacizumab in... Talazoparib Plus Enzalutamide Improves rPFS in First-Line Treatment for Patients with... Financial Navigation Can Reduce the Financial Toxicity of Cancer Care
